{"id":"https://openalex.org/W1963865415","doi":"https://doi.org/10.1038/sj.bjp.0705542","title":"Thymol, a constituent of thyme essential oil, is a positive allosteric modulator of human GABAA receptors and a homo\u2010oligomeric GABA receptor from Drosophila melanogaster","display_name":"Thymol, a constituent of thyme essential oil, is a positive allosteric modulator of human GABAA receptors and a homo\u2010oligomeric GABA receptor from Drosophila melanogaster","publication_year":2003,"publication_date":"2003-12-01","ids":{"openalex":"https://openalex.org/W1963865415","doi":"https://doi.org/10.1038/sj.bjp.0705542","mag":"1963865415","pmid":"https://pubmed.ncbi.nlm.nih.gov/14623762","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1574153"},"language":"en","primary_location":{"id":"doi:10.1038/sj.bjp.0705542","doi":"https://doi.org/10.1038/sj.bjp.0705542","is_oa":false,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0705542","pdf_url":null,"source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1963865415"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1574153/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074557964","display_name":"Caroline M. Priestley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I124357947","display_name":"University of London","ror":"https://ror.org/04cw6st05","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Caroline M Priestley","raw_affiliation_strings":["Department of Pharmaceutical and Biological Chemistry, The School of Pharmacy, 29-39 Brunswick Square, London WC1N 1AX. caroline.priestly@adas.co.uk","Centre for Pharmacognosy and Phytotherapy, Department of Pharmaceutical and Biological Chemistry, The School of Pharmacy, 29\u201039 Brunswick Square, London WC1N 1AX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical and Biological Chemistry, The School of Pharmacy, 29-39 Brunswick Square, London WC1N 1AX. caroline.priestly@adas.co.uk","institution_ids":[]},{"raw_affiliation_string":"Centre for Pharmacognosy and Phytotherapy, Department of Pharmaceutical and Biological Chemistry, The School of Pharmacy, 29\u201039 Brunswick Square, London WC1N 1AX","institution_ids":["https://openalex.org/I124357947"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048582362","display_name":"Elizabeth M. Williamson","orcid":"https://orcid.org/0000-0003-2034-7063","observed_orcids":["https://orcid.org/0000-0003-2034-7063"]},"institutions":[{"id":"https://openalex.org/I124357947","display_name":"University of London","ror":"https://ror.org/04cw6st05","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Elizabeth M Williamson","raw_affiliation_strings":["Centre for Pharmacognosy and Phytotherapy, Department of Pharmaceutical and Biological Chemistry, The School of Pharmacy, 29-39 Brunswick Square, London WC1N 1AX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Pharmacognosy and Phytotherapy, Department of Pharmaceutical and Biological Chemistry, The School of Pharmacy, 29-39 Brunswick Square, London WC1N 1AX","institution_ids":["https://openalex.org/I124357947"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072439028","display_name":"Keith A. Wafford","orcid":"https://orcid.org/0000-0002-8508-4738","observed_orcids":["https://orcid.org/0000-0002-8508-4738","https://orcid.org/0000-0003-4537-4690"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Keith A Wafford","raw_affiliation_strings":["Merck Sharp and Dohme, Neuroscience Research Centre, Terling's Park, Harlow, Essex CM20 2QR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp and Dohme, Neuroscience Research Centre, Terling's Park, Harlow, Essex CM20 2QR","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053484252","display_name":"David Barry Sattelle","orcid":"https://orcid.org/0000-0003-0705-5242","observed_orcids":["https://orcid.org/0000-0003-0705-5242"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David B Sattelle","raw_affiliation_strings":["MRC Functional Genetics Unit, Department of Human Anatomy and Genetics, University of Oxford, South Parks Road, Oxford, OX1 3QX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Functional Genetics Unit, Department of Human Anatomy and Genetics, University of Oxford, South Parks Road, Oxford, OX1 3QX","institution_ids":["https://openalex.org/I40120149"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5074557964"],"corresponding_institution_ids":["https://openalex.org/I124357947"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":1.1019,"has_fulltext":false,"cited_by_count":512,"citation_normalized_percentile":{"value":0.71033628,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"140","issue":"8","first_page":"1363","last_page":"1372"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11818","display_name":"Nicotinic Acetylcholine Receptors Study","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/thymol","display_name":"thymol","score":0.9980000257492065},{"id":"https://openalex.org/keywords/thyme-essential-oil","display_name":"thyme essential oil","score":0.9340000152587891},{"id":"https://openalex.org/keywords/gaba-a-receptor","display_name":"GABAA receptor","score":0.9089999794960022},{"id":"https://openalex.org/keywords/allosteric-modulation","display_name":"allosteric modulation","score":0.8330000042915344},{"id":"https://openalex.org/keywords/drosophila-melanogaster","display_name":"Drosophila melanogaster","score":0.9520000219345093},{"id":"https://openalex.org/keywords/monoterpenoids","display_name":"monoterpenoids","score":0.7039999961853027},{"id":"https://openalex.org/keywords/gaba-potentiation","display_name":"GABA potentiation","score":0.8579999804496765},{"id":"https://openalex.org/keywords/benzodiazepine-binding-site","display_name":"benzodiazepine binding site","score":0.6990000009536743},{"id":"https://openalex.org/keywords/site-of-action","display_name":"site of action","score":0.5360000133514404},{"id":"https://openalex.org/keywords/pentobarbital","display_name":"pentobarbital","score":0.7540000081062317},{"id":"https://openalex.org/keywords/propofol","display_name":"propofol","score":0.9959999918937683},{"id":"https://openalex.org/keywords/gaba-mimetics","display_name":"GABA mimetics","score":0.34700000286102295}],"concepts":[{"id":"https://openalex.org/C168258287","wikidata":"https://www.wikidata.org/wiki/Q60147","display_name":"GABAA receptor","level":3,"score":0.8886206150054932},{"id":"https://openalex.org/C2780642067","wikidata":"https://www.wikidata.org/wiki/Q408883","display_name":"Thymol","level":3,"score":0.6777419447898865},{"id":"https://openalex.org/C166342909","wikidata":"https://www.wikidata.org/wiki/Q845326","display_name":"Allosteric regulation","level":3,"score":0.5870586037635803},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.529653012752533},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4995880126953125},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.49066126346588135},{"id":"https://openalex.org/C2778409475","wikidata":"https://www.wikidata.org/wiki/Q421920","display_name":"Flumazenil","level":4,"score":0.4750521183013916},{"id":"https://openalex.org/C25274449","wikidata":"https://www.wikidata.org/wiki/Q1805481","display_name":"Long-term potentiation","level":3,"score":0.4612758159637451},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.35950928926467896},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3577575087547302},{"id":"https://openalex.org/C2777278459","wikidata":"https://www.wikidata.org/wiki/Q170885","display_name":"Essential oil","level":2,"score":0.0},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000494","descriptor_name":"Allosteric Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004331","descriptor_name":"Drosophila melanogaster","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009822","descriptor_name":"Oils, Volatile","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D009865","descriptor_name":"Oocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009865","descriptor_name":"Oocytes","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D011963","descriptor_name":"Receptors, GABA-A","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011963","descriptor_name":"Receptors, GABA-A","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D013943","descriptor_name":"Thymol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013943","descriptor_name":"Thymol","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D014982","descriptor_name":"Xenopus laevis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018408","descriptor_name":"Patch-Clamp Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018757","descriptor_name":"GABA Modulators","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D021122","descriptor_name":"Protein Subunits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D046930","descriptor_name":"Thymus Plant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1038/sj.bjp.0705542","doi":"https://doi.org/10.1038/sj.bjp.0705542","is_oa":false,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0705542","pdf_url":null,"source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:14623762","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14623762","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Comparative Study"},{"id":"pmh:oai:pubmedcentral.nih.gov:1574153","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1574153/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/58ddd5e7-c4ca-4f95-a3a1-28b0f764d659","doi":null,"is_oa":false,"landing_page_url":"https://research.manchester.ac.uk/en/publications/58ddd5e7-c4ca-4f95-a3a1-28b0f764d659","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Priestley, C M, Williamson, E M, Wafford, K A & Sattelle, D B 2003, 'Thymol, a constituent of thyme essential oil, is a positive allosteric modulator of human GABA A receptors and a homo-oligomeric GABA receptor from Drosophila melanogaster', British Journal of Pharmacology, vol. 140, no. 8, pp. 1363-1372. https://doi.org/10.1038/sj.bjp.0705542","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.652.6332","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.652.6332","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574153/pdf/140-0705542a.pdf","raw_type":"text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:1574153","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1574153/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"},"sustainable_development_goals":[{"score":0.428600013256073,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W197297906","https://openalex.org/W335574273","https://openalex.org/W1510360284","https://openalex.org/W1565551672","https://openalex.org/W1811017971","https://openalex.org/W1972994417","https://openalex.org/W1977433867","https://openalex.org/W1979602666","https://openalex.org/W1986602709","https://openalex.org/W1986853288","https://openalex.org/W1988214857","https://openalex.org/W1989151505","https://openalex.org/W1996339077","https://openalex.org/W1998119535","https://openalex.org/W1998765262","https://openalex.org/W2004010919","https://openalex.org/W2005558396","https://openalex.org/W2007197433","https://openalex.org/W2036378698","https://openalex.org/W2043840407","https://openalex.org/W2047819753","https://openalex.org/W2053256744","https://openalex.org/W2056204147","https://openalex.org/W2064887450","https://openalex.org/W2068284055","https://openalex.org/W2072349924","https://openalex.org/W2077712945","https://openalex.org/W2081025398","https://openalex.org/W2081084990","https://openalex.org/W2082304607","https://openalex.org/W2083228186","https://openalex.org/W2085809593","https://openalex.org/W2089154386","https://openalex.org/W2098953902","https://openalex.org/W2106124936","https://openalex.org/W2106915249","https://openalex.org/W2107253022","https://openalex.org/W2152959849","https://openalex.org/W2175074924","https://openalex.org/W2226113055","https://openalex.org/W2399146199","https://openalex.org/W2405577466","https://openalex.org/W2413732288","https://openalex.org/W2437611304","https://openalex.org/W4405991357","https://openalex.org/W4406059090","https://openalex.org/W4406065823"],"related_works":["https://openalex.org/W2023205553","https://openalex.org/W1982515390","https://openalex.org/W1968871784","https://openalex.org/W2027966030","https://openalex.org/W2011512341","https://openalex.org/W1598783475","https://openalex.org/W2007197433","https://openalex.org/W1896250322","https://openalex.org/W2077712945"],"abstract_inverted_index":{"The":[0,30,97],"GABA-modulating":[1],"and":[2,14,78,116,146,197],"GABA-mimetic":[3],"activities":[4],"of":[5,32,34,47,80,95,138,173,195,206,211],"the":[6,48,62,93,117,130,174,185,192],"monoterpenoid":[7],"thymol":[8,35,110,171,218],"were":[9,76],"explored":[10],"on":[11,129,199],"human":[12,148],"GABAA":[13,58,103,149,220],"Drosophila":[15],"melanogaster":[16],"homomeric":[17],"RDLac":[18,63],"GABA":[19,50,75,100,132,142,175],"receptors":[20,104,150,221],"expressed":[21],"in":[22,43,52,72,92],"Xenopus":[23],"laevis":[24],"oocytes,":[25],"voltage-clamped":[26],"at":[27,101,157,177,184],"-60":[28],"mV.":[29],"site":[31],"action":[33,207],"was":[36,105,126,151],"also":[37],"investigated.":[38],"Thymol,":[39],"1-100":[40],"microm,":[41,88,115],"resulted":[42],"a":[44,204,223],"dose-dependent":[45],"potentiation":[46,137,172],"EC20":[49,141],"response":[51,73,176],"oocytes":[53],"injected":[54],"with":[55,203],"either":[56,212],"alpha1beta3gamma2s":[57,102,147,178,200],"subunit":[59,64],"cDNAs":[60],"or":[61,159,187],"RNA.":[65],"At":[66],"100":[67,87],"microm":[68,109],"thymol,":[69,86],"current":[70],"amplitudes":[71],"to":[74,113,123,140],"416+/-72":[77],"715+/-85%":[79],"controls,":[81],"respectively.":[82],"On":[83],"both":[84],"receptors,":[85,179,201],"elicited":[89],"small":[90],"currents":[91],"absence":[94],"GABA.":[96],"EC50":[98],"for":[99,143],"reduced":[106],"by":[107],"50":[108],"from":[111,121,209],"15+/-3":[112],"4+/-1":[114],"Hill":[118],"slope":[119],"changed":[120],"1.35+/-0.14":[122],"1.04+/-0.16;":[124],"there":[125],"little":[127],"effect":[128],"maximum":[131],"response.":[133],"Thymol":[134,190],"(1-100":[135],"microm)":[136],"responses":[139],"alpha1beta1gamma2s,":[144],"alpha6beta3gamma2s":[145],"almost":[152],"identical,":[153],"arguing":[154],"against":[155,182],"actions":[156,183,194],"benzodiazepine":[158],"loreclezole":[160],"sites.":[161,189],"Neither":[162],"flumazenil,":[163],"3-hydroxymethyl-beta-carboline":[164],"(3-HMC),":[165],"nor":[166],"5alpha-pregnane-3alpha,":[167],"20alpha-diol":[168],"(5alpha-pregnanediol)":[169],"affected":[170],"providing":[180],"evidence":[181],"benzodiazepine/beta-carboline":[186],"steroid":[188],"stimulated":[191],"agonist":[193],"pentobarbital":[196],"propofol":[198],"consistent":[202],"mode":[205],"distinct":[208],"that":[210,217],"compound.":[213],"These":[214],"data":[215],"suggest":[216],"potentiates":[219],"through":[222],"previously":[224],"unidentified":[225],"binding":[226],"site.":[227]},"counts_by_year":[{"year":2026,"cited_by_count":17},{"year":2025,"cited_by_count":25},{"year":2024,"cited_by_count":22},{"year":2023,"cited_by_count":28},{"year":2022,"cited_by_count":37},{"year":2021,"cited_by_count":31},{"year":2020,"cited_by_count":41},{"year":2019,"cited_by_count":32},{"year":2018,"cited_by_count":26},{"year":2017,"cited_by_count":26},{"year":2016,"cited_by_count":25},{"year":2015,"cited_by_count":23},{"year":2014,"cited_by_count":34},{"year":2013,"cited_by_count":30},{"year":2012,"cited_by_count":32}],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2016-06-24T00:00:00"}